42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08b-1364118
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 2c00e0f9-3710-42d6-a2ae-c364adf5024f
[Document ID] => 1364118
[Document naam] => AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo/document/VWS-WOO-08b-1364118
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08b-1364118
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo
[DocumentPublicationDate] => 23 november 2020
[DocumentStatusCheckedDate] => 2026-04-27 20:51:16.038179
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 09:38:28
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 09:38:28
)
Document: VWS-WOO-08b-1364118
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201123
Geregistreerde documentnaam: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| document_SectionDownloadButton | 1 | 2025-09-01 08:59:12 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 08:59:12 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 08:59:12 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking_documenten | 6.493 | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking_paginas | 23.875 | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo/file/download/inventory | 2025-06-22 23:51:05 |
| document_documentName | AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 | 2025-06-22 23:51:05 |
| document_documentType | E-mailbericht | 2025-06-22 23:51:05 |
| document_documentPublicationDate | 2020-11-23 | 2025-06-22 23:51:05 |
| document_documentNumber | VWS-WOO-08b-1364118 | 2025-06-22 23:51:05 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:51:05 |
| document_SectionHTMLDataDivs | 2 | 2025-06-22 23:51:05 |
| document_SectionAbout | 1 | 2025-06-22 23:51:05 |
| About_Datum document | 23 november 2020 | 2025-06-22 23:51:05 |
| About_Type bronbestand | E-mailbericht, 1 pagina's | 2025-06-22 23:51:05 |
| About_Type bronbestand_paginas | 1 | 2025-06-22 23:51:05 |
| About_Download als | PDF (636.47 KB) | 2025-06-22 23:51:05 |
| About_Documentnummer | 1364118 | 2025-06-22 23:51:05 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:51:05 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 (documentnummer 1ef09279-f988-61c0-af5e-cb1f2dce5f23) | 2025-06-22 23:51:05 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:51:05 |
| document_SectionRequest | 1 | 2025-06-22 23:51:05 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over Vaccinaties | 2025-06-22 23:51:05 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo | 2025-06-22 23:51:05 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over Vaccinaties | 2025-06-22 23:51:05 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 29 februari 2024 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Cluster Vaccinaties en Medicatie. | 2025-06-22 23:51:05 |
| Request_Periode | Januari 2020 t/m maart 2023 | 2025-06-22 23:51:05 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:51:05 |
| Request_Datum besluit | 29 februari 2024 | 2025-06-22 23:51:05 |
| Request_Omvang openbaarmaking | 6.493 documenten, 23.875 pagina's Inventarislijst | 2025-06-22 23:51:05 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08b-1364118.pdf | 2025-04-19 23:09:21 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3755967-1060180-pdo/file/download/document/1ef09279-f988-61c0-af5e-cb1f2dce5f23 | 2025-04-19 23:09:21 |
| DocumentDownload_linkname | Download (pdf, 636.47 KB) | 2025-04-19 23:09:21 |
Archiefversies (9 rijen)
Archiefrij 1 — 2025-11-21 15:49:28
fromFile: VWS-WOO-3755967-1060180-pdo-1f0a50a6-cb61-6ff8-8b0f-91d3fb5eede4.zip
fromFilePath: archieven_files\VWS-WOO-3755967-1060180-pdo-1f0a50a6-cb61-6ff8-8b0f-91d3fb5eede4.zip
documentName: VWS-WOO-08b-1364118.pdf
documentType: pdf
documentCompressedSize: 523541
documentSize: 651749
documentCompressRatio: 80.32862344246021
documentDateModified: 2025-10-09 12:23:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:49:28
lastSeen: 2025-11-21 15:49:28
text: 1364118
To:
@minvws.nl]
@astrazeneca.com]
Cc:
From
5.1.2e
Sent:
Mon 11/23/2020 7:18:39 AM
Subject:
AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Received:
5.1.2e
Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNS
FINAL .pdf
Dear Minister De Jonge, Minis...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a49a8479cf04fd28c53e174fbc90102a9fa1541861bbf37b17523a89a7468d89
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 9c9dd9da-0b6b-41e0-a690-94033050cfdf
textDigestSHA256: 77da1fc17ac96582108db2b3a1bc6e8673e25c861228d73e48d1590c432a2fb1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
Archiefrij 2 — 2025-11-21 15:46:06
fromFile: VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.zip
documentName: VWS-WOO-08b-1364118.pdf
documentType: pdf
documentCompressedSize: 523541
documentSize: 651749
documentCompressRatio: 80.32862344246021
documentDateModified: 2025-10-09 12:23:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:46:06
lastSeen: 2025-11-21 15:46:06
text: 1364118
To:
@minvws.nl]
@astrazeneca.com]
Cc:
From
5.1.2e
Sent:
Mon 11/23/2020 7:18:39 AM
Subject:
AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Received:
5.1.2e
Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNS
FINAL .pdf
Dear Minister De Jonge, Minis...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a49a8479cf04fd28c53e174fbc90102a9fa1541861bbf37b17523a89a7468d89
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 0e19e060-3ead-4118-b20a-d8b31f0f1736
textDigestSHA256: 77da1fc17ac96582108db2b3a1bc6e8673e25c861228d73e48d1590c432a2fb1
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
Archiefrij 3 — 2025-09-07 17:19:19
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08b-1364118.pdf
documentName: VWS-WOO-08b-1364118.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 651749
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:19:19
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:19:19
lastSeen: 2025-09-07 17:19:19
text: 1364118
To: @minvws.nl]
Cc: @astrazeneca.com]
From 5.1.2e 5.1.2e
Sent: Mon 11/23/2020 7:18:39 AM
Subject: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint inpreventing COVID-19
Received:Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNSFINAL.pdf
Dear Minister DeJonge,Minister Van Ark,
We arep...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a49a8479cf04fd28c53e174fbc90102a9fa1541861bbf37b17523a89a7468d89
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_12096_ddcc9965a77e2e79e9dcd8b73ab624a4
textDigestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
Archiefrij 4 — 2025-09-04 17:16:09
fromFile: VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.1.zip
documentName: VWS-WOO-08b-1364118.pdf
documentType: pdf
documentCompressedSize: 523541
documentSize: 651749
documentCompressRatio: 80.32862344246021
documentDateModified: 2025-05-01 20:40:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:16:09
lastSeen: 2025-11-21 13:47:41
text: 1364118 To: @minvws.nl] @astrazeneca.com] Cc: From 5.1.2e Sent: Mon 11/23/2020 7:18:39 AM Subject: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 Received: 5.1.2e Mon 11/23/2020 7:18:54 AM AZD1222 HLR RNS FINAL .pdf ...
noTextDate: leeg!
ocrText: 1227720 Artikel ArtikeIType, ArtikelFarmaceut ArtikelDescription ArtikelCategorie ArtikelAantal ArtikelEenheid, ArtikelHoeveelheid, ArtikelHoeveelheid Flacons,ArtikelHoeveelheidDosesPerTray ArtikelHoeveelheidDoses, ArtikelAfnemer ArtikelAfnemerGroep, ArtikelAfgiftedatum , ArtikelStatus, ArtikelAfze...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a49a8479cf04fd28c53e174fbc90102a9fa1541861bbf37b17523a89a7468d89
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: VWS-WOO-3755967-1060180-pdo-1f026c98-b5e5-6728-804f-65673e0af118.zip_1627
textDigestSHA256: 109cf119f1fd04c644648a66a7d9b3bfc08790df545674cc9d64dbed7fb525eb
ocrTextDigestSHA256: cbb318e36bc801b51a4e835f266ccf9e2f2591f7587882f9cceab6e8131f83fb
extractedId: VWS-WOO-08b-1364118
Archiefrij 5 — 2025-03-21 07:59:42
fromFile: 2024.075-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1364118-AstraZenecaOxford_AZD1222_vaccine_met_primary_efficacy_endpoint_in_preventing_COVID-19.pdf
documentType: pdf
documentCompressedSize: 522634
documentSize: 651749
documentCompressRatio: 80.18945943913991
documentDateModified: 2024-10-30 14:22:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-21 07:59:42
lastSeen: 2025-03-21 07:59:42
text: 1364118
To: @minvws.nl]
Cc: @astrazeneca.com]
From 5.1.2e 5.1.2e
Sent: Mon 11/23/2020 7:18:39 AM
Subject: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint inpreventing COVID-19
Received:Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNSFINAL.pdf
Dear Minister DeJonge,Minister Van Ark,
We arep...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 395306
textDigestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
Archiefrij 6 — 2025-03-18 09:30:27
fromFile: 2023.022-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.022-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1364118-AstraZenecaOxford_AZD1222_vaccine_met_primary_efficacy_endpoint_in_preventing_COVID-19.pdf
documentType: pdf
documentCompressedSize: 522634
documentSize: 651749
documentCompressRatio: 80.18945943913991
documentDateModified: 2024-10-30 14:22:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:27
lastSeen: 2025-03-18 09:30:27
text: 1364118
To: @minvws.nl]
Cc: @astrazeneca.com]
From 5.1.2e 5.1.2e
Sent: Mon 11/23/2020 7:18:39 AM
Subject: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint inpreventing COVID-19
Received:Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNSFINAL.pdf
Dear Minister DeJonge,Minister Van Ark,
We arep...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 370958
textDigestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
Archiefrij 7 — 2025-02-27 09:25:07
fromFile: 2023.031-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.031-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1364118-AstraZenecaOxford_AZD1222_vaccine_met_primary_efficacy_endpoint_in_preventing_COVID-19.pdf
documentType: pdf
documentCompressedSize: 522634
documentSize: 651749
documentCompressRatio: 80.18945943913991
documentDateModified: 2024-10-30 14:22:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:07
lastSeen: 2025-02-27 09:25:07
text: 1364118
To: @minvws.nl]
Cc: @astrazeneca.com]
From 5.1.2e 5.1.2e
Sent: Mon 11/23/2020 7:18:39 AM
Subject: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint inpreventing COVID-19
Received:Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNSFINAL.pdf
Dear Minister DeJonge,Minister Van Ark,
We arep...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 12, "email": "@minvws.nl", "context": "1364118 To: @minvws.nl] Cc: @astrazeneca.com] From"}, {"position": 28, "email": "@astrazeneca.com", "context": "To: @minvws.nl] Cc: @astrazeneca.com] From 5.1.2e 5.1.2e"}, {"position": 2235, "email": "@astrazeneca.com", "context": "AstraZeneca M:EEE 512 |@astrazeneca.com T-431 ZeEneca.com AstraZeneca"}]
documentMailAdresses: [{"position": 12, "email": "@minvws.nl", "context": "1364118 To: @minvws.nl] Cc: @astrazeneca.com] From"}, {"position": 28, "email": "@astrazeneca.com", "context": "To: @minvws.nl] Cc: @astrazeneca.com] From 5.1.2e 5.1.2e"}, {"position": 2235, "email": "@astrazeneca.com", "context": "AstraZeneca M:EEE 512 |@astrazeneca.com T-431 ZeEneca.com AstraZeneca"}]
digestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 284129
textDigestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
Archiefrij 8 — 2025-02-27 09:25:00
fromFile: 2023.011-VWS-WOO-3755967-1060180-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.011-VWS-WOO-3755967-1060180-pdo.zip
documentName: VWS-WOO-08b-1364118-AstraZenecaOxford_AZD1222_vaccine_met_primary_efficacy_endpoint_in_preventing_COVID-19.pdf
documentType: pdf
documentCompressedSize: 522634
documentSize: 651749
documentCompressRatio: 80.18945943913991
documentDateModified: 2024-10-30 14:22:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:00
lastSeen: 2025-02-27 09:25:00
text: 1364118
To: @minvws.nl]
Cc: @astrazeneca.com]
From 5.1.2e 5.1.2e
Sent: Mon 11/23/2020 7:18:39 AM
Subject: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint inpreventing COVID-19
Received:Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNSFINAL.pdf
Dear Minister DeJonge,Minister Van Ark,
We arep...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 12, "email": "@minvws.nl", "context": "1364118 To: @minvws.nl] Cc: @astrazeneca.com] From"}, {"position": 28, "email": "@astrazeneca.com", "context": "To: @minvws.nl] Cc: @astrazeneca.com] From 5.1.2e 5.1.2e"}, {"position": 2235, "email": "@astrazeneca.com", "context": "AstraZeneca M:EEE 512 |@astrazeneca.com T-431 ZeEneca.com AstraZeneca"}]
documentMailAdresses: [{"position": 12, "email": "@minvws.nl", "context": "1364118 To: @minvws.nl] Cc: @astrazeneca.com] From"}, {"position": 28, "email": "@astrazeneca.com", "context": "To: @minvws.nl] Cc: @astrazeneca.com] From 5.1.2e 5.1.2e"}, {"position": 2235, "email": "@astrazeneca.com", "context": "AstraZeneca M:EEE 512 |@astrazeneca.com T-431 ZeEneca.com AstraZeneca"}]
digestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 193074
textDigestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
Archiefrij 9 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-2ddff5cf6308781f1485177c04b12fc0a19bb773f8e1b2f357c77b148697d12a.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-2ddff5cf6308781f1485177c04b12fc0a19bb773f8e1b2f357c77b148697d12a.zip
documentName: VWS-WOO-08b-1364118-AstraZenecaOxford_AZD1222_vaccine_met_primary_efficacy_endpoint_in_preventing_COVID-19.pdf
documentType: pdf
documentCompressedSize: 522634
documentSize: 651749
documentCompressRatio: 80.18945943913991
documentDateModified: 2024-10-30 14:22:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1364118
To: @minvws.nl]
Cc: @astrazeneca.com]
From 5.1.2e 5.1.2e
Sent: Mon 11/23/2020 7:18:39 AM
Subject: AstraZeneca/Oxford AZD1222 vaccine met primary efficacy endpoint inpreventing COVID-19
Received:Mon 11/23/2020 7:18:54 AM
AZD1222 HLR RNSFINAL.pdf
Dear Minister DeJonge,Minister Van Ark,
We arep...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 12, "email": "@minvws.nl", "context": "1364118 To: @minvws.nl] Cc: @astrazeneca.com] From"}, {"position": 28, "email": "@astrazeneca.com", "context": "To: @minvws.nl] Cc: @astrazeneca.com] From 5.1.2e 5.1.2e"}, {"position": 2235, "email": "@astrazeneca.com", "context": "AstraZeneca M:EEE 512 |@astrazeneca.com T-431 ZeEneca.com AstraZeneca"}]
documentMailAdresses: [{"position": 12, "email": "@minvws.nl", "context": "1364118 To: @minvws.nl] Cc: @astrazeneca.com] From"}, {"position": 28, "email": "@astrazeneca.com", "context": "To: @minvws.nl] Cc: @astrazeneca.com] From 5.1.2e 5.1.2e"}, {"position": 2235, "email": "@astrazeneca.com", "context": "AstraZeneca M:EEE 512 |@astrazeneca.com T-431 ZeEneca.com AstraZeneca"}]
digestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 73224
textDigestSHA256: c1a137fb2cbe5a724c85a5d63f86615033f90b3c17a3f5e77cf609020f62e0b2
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08b-1364118
(dit is ook een speeltuin)